coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Medway Rainham PCN, Medway (LAD) · Health Inequalities Profile

    PCN U61151 · NHS Kent and Medway Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    39,636

    Registered population

    55.7% aged 18–64

    24.4%

    Aged 65+

    ICB 19.9% · England 17.9%

    8.3%

    Ethnic minority (non-White)

    3.6% Asian · England 9.6%

    4.6%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~1,718

    Core20 residents (est.)

    Resident basis; registered basis ~1,926 · see page 3

    7,618

    Hypertension register

    +3.97% in 3 yrs · England +5.60%

    238

    SMI register

    8.4% of Medway (LAD)'s

    690

    COPD register

    Reviews -14.97% in 3 yrs

    Forecast to 2030

    8,536

    Hypertension patients, 2030

    +918 on today

    75.0%

    QRISK ≥20% on statins, 2030

    +4.88pp over 3 yrs

    5.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -21.7%
    Asthma annual review coverage fell over three years.

    Asthma reviews fell 21.7% (England +4.4%) to 60.7% (England 65.7%), a scale of about 920 unreviewed patients, which may reflect unverified recall lags.

    46.9 pp
    Core20 deprivation is concentrated in two practices.

    Practice Core20 shares span 46.9 pp, reaching 46.9% at Waltham Road Medical Centre (620 estimated patients) and 22.9% at Eastcourt Lane Surgery (534).

    86.4%
    Older-adult blood pressure control exceeds national benchmarks.

    Blood pressure control in patients aged 80+ is 86.4% (England 81.2%; Medway (LAD) 79.4%), rising +6.3% over three years against England's +2.2%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults aged 65+ make up 24.4% of patients, exceeding England's 17.9%

    Medway Rainham PCN serves 39,636 registered patients across eight practices. The population is older than benchmarks: 24.4% (9,685 patients) are aged 65+, above Medway (LAD) (17.9%), NHS Kent and Medway ICB (19.9%), and England (17.9%). Working-age adults represent 55.7% (22,068 patients) and children 19.9% (7,883 patients). Projected list growth to 2030 is +2.5% (Medway (LAD) +7.0%, ICB +6.0%, England +2.3%; unverified methodology). Census resident data, not registered ethnicity, records 91.7% White (Medway (LAD) 84.3%, ICB 88.6%, England 81.1%) and 3.6% Asian / Asian British (Medway (LAD) 5.9%, ICB 4.7%, England 9.6%).

    Age profile

    0–1719.9%
    18–6455.7%
    65+24.4%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White91.7%
    Asian3.6%
    Mixed2.1%
    Black1.9%
    Other0.7%

    Older people · falls rows are Medway (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Medway LA)1,5072,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.7%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Medway LA)7409819552024/25
    Falls deaths, all ages, per 100,000 (Medway LA)19.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Overall Core20 deprivation is 4.6% but practice shares span 46.9 percentage points

    Medway Rainham PCN's Core20 share is 4.6%, below Medway (LAD) at 23.1%, NHS Kent and Medway ICB at 17.1%, and England at 21.0% (average IMD decile 6.9). Practice shares span 46.9 pp, concentrated at Waltham Road Medical Centre (46.9%, 620 estimated patients) and Eastcourt Lane Surgery (22.9%, 534 patients). Registered practice estimates total 1,926 patients, differing from the 1,718 resident estimate. Targeted outreach and proactive reviews should prioritise these two concentrated practices rather than diluting resources across the PCN.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Waltham Road46.9% · 620 patients
    Eastcourt Lane22.9% · 534 patients
    Orchard6.6% · 365 patients
    Long Catlis Road2.4% · 264 patients
    Thames Ave2.4% · 143 patients
    Maidstone Rd0.0% · 0 patients
    Wigmore0.0% · 0 patients
    Parkwood0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    238

    SMI register

    0.60% recorded prevalence

    183

    Learning disability register

    0.46% recorded prevalence

    13

    Care homes, 358 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Medway (LAD), Census 2021

    The PCN records 238 patients on the severe mental illness register (0.6%) and 183 on the learning disability register (0.5%), both trailing Medway (LAD) (0.9%, 0.7%), NHS Kent and Medway ICB (0.9%, 0.6%), and England (1.0%, 0.6%). Catchment services include 13 care homes (358 beds). Separately, Medway (LAD) reports an 8.9% unpaid care rate and 11 rough sleepers in 2025.

    Severe mental illness: physical health checks

    SMI prevalence is 0.6% (England 1.0%). Annual BP checks reach 84.6% (England 83.4%) and BMI checks reach 83.4% (England 82.1%), but alcohol recording fell 1.3 pp over three years (England +5.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,618

    Hypertension register

    +3.97%

    Register growth, 3 yrs

    Medway (LAD) +3.74% · England +5.60%

    +0.18pp

    BP control, under 80

    ≤140/90 · +5.10pp aged 80+

    +918

    More patients by 2030

    Forecast 8,536 (20.80%)

    Hypertension case-finding and control

    Hypertension prevalence is 19.2% (7,618 patients), above Medway (LAD) (15.4%), NHS Kent and Medway ICB (16.2%) and England (15.2%), though crude prevalence is not age-adjusted. Blood pressure control in patients aged 80+ is 86.4% (England 81.2%), rising +6.3% over three years (England +2.2%). Conversely, recent blood pressure recording stands at 87.9% (England 90.0%) after slower three-year growth of +1.9% (England +3.6%). Furthermore, three-year control progress for under-80s (+0.3%) trails England (+3.2%), despite current control reaching 71.5% (England 67.8%). Slower three-year control progress for under-80s compared with England suggests reviewing working-age recall and titration processes.

    Lipids and statins

    Lipid-lowering therapy reaches 64.0% of patients with QRISK ≥ 20%, in line with Medway (LAD) (64.0%) and above England (63.6%). Statin treatment is 74.8% in chronic kidney disease (England 70.3%) and 74.7% for primary prevention in diabetes (England 73.2%). Treatment coverage exceeds England across high-risk groups, so the priority is sustaining proactive recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202675,462£2.40£1.90£1.86£181,109
    Cardiovascular (all), 202584,445£3.44£3.57£3.33£290,491

    In 2026, lipid-modifying prescribing cost £2.40 per item, above Medway (LAD) (£1.87), NHS Kent and Medway ICB (£1.90) and England (£1.86). Across 75,462 items, spend is £40,749 more than at England's unit cost. Prescribing unit costs exceed benchmarks, indicating an opportunity for clinical pharmacists to review lipid-modifying formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −21.69%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.52%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual review coverage fell 21.7% over three years to 60.7% (England +4.4% to 65.7%; Medway (LAD) 62.6%), leaving an unadjusted scale of about 920 of 2,339 registered asthma patients without a recorded review. COPD reviews similarly dropped 15.0% to 70.6% across 690 patients (England +2.8% to 76.4%; Medway (LAD) 74.3%). Conversely, youth asthma second-hand smoking status recording reached 89.1% (England 78.8%). Falling adult reviews across both pathways may indicate recall capacity pressures or coding delays, unverified locally.

    Cancer register and children's immunisation

    Recorded cancer prevalence is 4.7% (1,871 patients; England 3.8%). In childhood immunisations, 24-month completion exceeds the 95.0% target (6-in-1 at 97.5%, MMR dose 1 at 96.2%). However, 12-month 6-in-1 coverage is 89.3% (below target by 5.7 pp; England 91.0%), and age-5 MMR dose 2 is 90.9% (below target by 4.1 pp), with a 20 pp dose difference at Eastcourt Lane Surgery. Catch-up call-and-recall should focus on pre-school boosters and infant immunisation timeliness.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.3%

    England 91.0%

    6-in-1 complete primary course at 24 months97.5%

    England 92.2%

    MMR dose 1 at 24 months96.2%

    England 88.3%

    MMR dose 2 at age 590.9%

    England 82.8%

    4-in-1 pre-school booster at age 589.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Cancer stage at diagnosis is not published at PCN level. In NHS Kent and Medway ICB, 55.6% of cancers were diagnosed at stage 1 or 2 in 2022 (4,661 of 8,384 with known stage; England 55.3%; distance to National ambition by 2028: -19.4 pp). Staging was known for 63.6% of ICB cancers (8,384 of 13,189; England 67.0%), an illustrative gap of about 1,630 early-stage cases. At PCN level, cervical screening coverage (ages 25-49) is 75.5% (England 66.8%), with a 3-year change of -2.7% (England -1.0%, Medway (LAD) +2.6%), falling to 67.9% at Long Catlis Road Surgery and 74.5% at Eastcourt Lane Surgery.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Cancer waits describe provider performance rather than PCN referrals. Medway NHS Foundation Trust exceeded the 75.0% 28-day faster diagnosis standard by 2.8 pp and the 96.0% 31-day combined treatment standard by 3.6 pp. However, the trust fell below the 85.0% 62-day referral to treatment standard by 3.4 pp. Across NHS Kent and Medway Integrated Care Board, 62-day performance was 9.1 pp below the 85.0% standard, while 28-day faster diagnosis was 1.8 pp above the 75.0% standard.

    Pathways within standard (%)MedwayMaidstone and Tunbridge WellsMid and South EssexKent and Medway ICBEngland
    28-day faster diagnosis (75%)77.7781.7867.4576.7879.32
    31-day treatment (96%)99.6298.3581.8895.8492.50
    62-day referral to treatment (85%)81.6487.4350.2575.9371.16
    Diagnostic waits over 6 weeks (%)MedwayMaidstone and Tunbridge WellsMid and South EssexEngland
    MRI0.680.9223.3521.40
    CT0.000.516.079.92
    Echocardiography36.622.5765.0528.48
    Colonoscopy1.8819.8064.0930.83
    Gastroscopy3.3224.0359.7629.02
    All 15 DM01 tests14.206.4241.5423.14
    Community services activityMedway residentsKent and Medway ICB
    Care contacts43,510254,055
    Referrals8,58068,085
    Patients with a contact11,54072,060

    Community services (residents of Medway), Jun 2026 (provisional). In Medway, community health service activity recorded 43,510 contacts with local authority residents in Jun 2026 (provisional), of which 26,985 involved adults aged 65 and over, a 62% share. While these borough figures show substantial older-adult contact volume across community services, they represent resident activity rather than PCN-specific delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 49.1 pp and vaccination achievement spans 61.6 pp across practices

    In 2025/26, QOF vaccination and immunisation achievement spanned 61.6 pp across practices, from 38.4% at Orchard Family Practice to 100.0% at Waltham Road Medical Centre. Overall QOF achievement was 65.3% at Long Catlis Road Surgery and 100.0% at Waltham Road Medical Centre. Clinical domain achievement was 63.4% at Long Catlis Road Surgery and 100.0% at Waltham Road Medical Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Maidstone Rd1140.093.1%75.7%94.8%
    Thames Ave Surgery1162.484.9%68.9%93.8%
    Orchard1066.668.2%63.4%92.8%
    Waltham Road11046.984.8%46.6%91.2%
    Eastcourt Lane10322.986.6%58.2%84.4%
    Parkwood1280.055.4%55.8%77.7%
    Wigmore1020.061.4%68.4%71.7%
    Long Catlis Road1102.444.0%57.1%71.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNMedway (LAD)AssetPCNMedway (LAD)
    Care homes (catchment)13 (358 beds)n/aSchools (catchment)54n/a
    Children's centres419Places of worship29110
    Libraries29Food banks (VCS)n/a6
    Homelessness support (VCS)n/a9Day centres (VCS)629
    Children and young people (VCS)1265Carers support groups (VCS)122
    Primary schools (LA maintained)817Primary academies1256

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Respiratory annual review recall redesign

    Asthma reviews fell 21.7% over 3 years to 60.7% (England +4.4% to 65.7%), an unadjusted scale of about 920 of 2,339 patients unreviewed; COPD fell 15.0% to 70.6% (690 patients). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Learning disability register validation audit

    Learning disability prevalence is 0.5% (183 of 39,636 registered patients) after a 1.9% 3-year fall (England 0.6%, +5.4%; Medway (LAD) 0.7%, +4.3%), a modelled gap of +50 to +90 patients. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    Under-eighty hypertension and lipid review

    Hypertension BP recording is 87.9% (England 90.0%) and under-80s control rose +0.3% over 3 years (England +3.2%); lipid-modifying drugs cost £2.40 per item, £40,749 more than England's £1.86 across 75,462 items. For discussion: clinical pharmacists could combine under-80s blood pressure recall and titration with a formulary review of lipid-modifying prescribing. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted deprivation review clinics (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness check review (p4)Patients with psychosis who have a current record of alcohol consumptionMHIS · From Harm to HopePCN
    Under-eighty blood pressure recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Respiratory annual review recall redesign (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Learning disability register validation audit (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 3 · Under-eighty hypertension and lipid review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15